Xlife Sciences financials at a glance
| Year | Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
CHF0.51M | CHF0.40M | CHF0.81M | CHF1.03M | CHF0.99M | CHF0.00M |
| GM % | Gross Margin % |
|
34.77% | -6.45% | 44.55% | 18.06% | 45.43% | 0.00% |
| OM | Operating Margin |
|
-149.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
CHF2.00 | CHF2.08 | CHF0.00 | |||
| Div. | Dividends |
|
CHF0.00 | CHF0.00 | CHF0.00 | CHF0.00 | CHF0.00 | CHF0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0m | 0m | 4.89m | 5.28m | 5.59m | 5.59m |
| OCF | Operating Cash Flow |
|
CHF-0.40M | CHF-0.40M | CHF-4.32M | CHF-4.61M | CHF0.17M | CHF0.00M |
| FCF | Free Cash Flow |
|
CHF-0.42M | CHF-0.46M | CHF-4.48M | CHF-4.69M | CHF-5.00M | CHF0.00M |
| FCFS | Free Cash Flow Per Share |
|
CHF-0.12 | CHF-0.16 | CHF-1.17 | CHF-0.89 | CHF0.02 | CHF0.00 |